Researchers uncover why a rare disease resulting in abnormal fat loss can also lead to diabetes

Help from patients with FPLD2 reveals answers

5:00 AM

Author | Kelly Malcom

group of people smiling and posing with white hat
“We also can’t overstate the importance of the patient population and their involvement in developing therapies and their dedication to understanding their disease," noted Ormond MacDougald, Ph.D. Credit: Kate Stratton/Lipodystrophy United

Many people may have a dim view of their fat tissue, yet scientists have come to recognize adipose as a necessary and metabolically active organ, carrying out many vital functions within the body.

In the case of obesity, too much fat can contribute to conditions such as diabetes and heart disease.

Intriguingly, for people with certain rare genetic and autoimmune disorders, such as familial partial lipodystrophy type 2, the abnormal loss and distribution of adipose tissue can also lead to diabetes and metabolic disease.

This paradox had long vexed Elif Oral, M.D., a clinician and Professor in the Division of Metabolism, Endocrinology and Diabetes.

She’s dedicated her research career to uncovering the underlying mechanism of pathological fat loss, to help patients with lipodystrophy syndromes.

With the generous help of patients with FPLD2, Oral along with Ormond MacDougald, Ph.D., Professor of Molecular & Integrative Physiology, graduate student researcher Jessica Maung, Ph.D., and their collaborative team have finally found some answers.

“A simple explanation is that all of the fat cells (adipocytes) have really catastrophic things happening in them,” said Maung.

The team created a mouse model in which they inducibly knocked out the lamin A/C gene in adipocytes, which is mutated in patients with FPLD2.

The team observed in both animal models and in patient donor tissue that dramatic gene expression changes lead to the fat cells being unable to carry out their normal lipid handling and storage functions.

In addition, the fat cells themselves and the immune cells within adipose tissue became pro-inflammatory.

Finally, mitochondria inside the fat cells became dysfunctional.

Said Maung, “All of these effects come together to create this perfect environment for the tissue to be really unhealthy and eventually disappear.”

In the absence of healthy adipose tissue, the normal maintenance of lipids and release of metabolic hormones goes awry, leading to metabolic diseases like diabetes and fatty liver disease.

“This is really underscoring the importance of healthy fats in keeping metabolism intact and functional,” said Oral.

“People think of Type 2 diabetes as a disease of beta cells, but it’s actually a disease of fat cells, too.”

The team hopes that these insights will help identify future therapeutic targets, enable targeting of adipose tissue to prevent it from disappearing, and correct metabolic dysfunction in this disease.

"This research finally shows us why our fat cells fail, not just that they do. The finding that metabolic disruption begins before visible fat loss even occurs is a gamechanger for how we think about early intervention. As both a patient and a research advocate, I see this study as a roadmap toward the targeted treatments our community desperately needs," said Sharon Halperin, Research Director of Lipodystrophy United, an advocacy and support organization.

“I think this work is an outstanding example of a collaboration between a translational clinical researcher and a basic science physiologist,” said MacDougald.

“We also can’t overstate the importance of the patient population and their involvement in developing therapies and their dedication to understanding their disease.”

Additional authors: Rebecca L. Schill, Akira Nishii, Maria Foss de Freitas, Bonje N. Obua, Marcus Nygård, Maria D. Mendez-Casillas, Isabel D.K. Hermsmeyer, Donatella Gilio, Ozge Besci, Yang Chen, Brian Desrosiers, Rose E. Adler, Anabela D. Gomes, Merve Celik Guler, Hiroyuki Mori, Romina M. Uranga, Ziru Li, Hadla Hariri, Liping Zhang, Anderson de Paula Souza, Keegan S. Hoose, Kenneth T. Lewis, Taryn A. Hetrick, Paul Cederna, Carey N. Lumeng, Susanne Mandrup

Paper cited: “Altered lipid metabolism and inflammatory programs associated with adipocyte loss in familial partial lipodystrophy 2,” The Journal of Clinical Investigation. DOI: 0.1172/JCI198387

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.


More Articles About:

Basic Science and Laboratory Research Diabetes Obesity & Weight Management Genetics All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

portrait of Ormond Macdougald

Ormond A MacDougald

Professor

elif oral

Elif A Oral

Professor

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

A stylized digital image of an X-ray of a human skeleton superimposed on a strand of DNA
Health Lab

Bigger data reveals the second, third, and fourth switches controlling a gene

A University of Michigan study reveals the untapped potential of the NIH-sponsored Trans-Omics for Precision Medicine (TOPMed) program
layers of skin pink to yellow
Health Lab

Study outlines a new framework for direct cell reprogramming

In a new paper published in the journal iScience, Lindsey Muir, Ph.D. and her lab at Michigan Medicine propose a framework for direct cell reprogramming.
Minding memory above a microphone on a blue background
Minding Memory

Is the United States Lagging Behind Europe in Memory Improvement?

In this episode, Lauren & Matt speak with Neil Mehta, PhD who is the associate dean for research and a professor in the Department of Epidemiology at the University of Texas Medical Branch in Galveston. Dr. Mehta’s research focuses on US life expectancy trends, the effects of obesity on disability and mortality, the sources of socioeconomic status disparities in mortality, and patterns of health in the United States and Europe. Dr. Mehta talks about a recent manuscript from the NIA-funded TRENDS study called “Trends in Memory Function and Memory Impairment Among Older Adults in the United States and Europe, 1996 to 2018.”, which looks at data from several sources to compare trends in memory function across 13 different countries.
people crowd aerial network connections
Health Lab

New insight into how lipodystrophy can affect overall health

What is lipodystrophy? Expert insights on partial vs. generalized fat loss, health complications, leptin therapy, and emerging clinical research.
red blood cells going through clear tube red background
Health Lab

FDA-approved drug offers hope for patients with polycythemia vera, a rare bone marrow disorder

FDA-approved rusfertide offers new hope for polycythemia vera patients by reducing phlebotomy dependence, easing symptoms, and improving daily life.
cells close up blue and green background microscope
Health Lab

Engineered nanoparticles sensitize gliomas to radiotherapy

University of Michigan researchers discovered a new pathway that sensitizes mIDH1 gliomas to radiation in human and mouse mIDH1 glioma cells and mouse models, paving the way for phase 1 clinical trials in humans